European Archives - Page 332 of 1101 - European Medical Journal

EMJ Gastroenterology 12.1 2023

Dive into EMJ Gastroenterology now, to explore an array of peer-reviewed articles, exclusive interviews with leading experts in the…

A Non-invasive and Useful Method for Screening Patients with Superficial Hypopharyngeal Cancer

With the progress in upper gastrointestinal endoscopic technology, the usefulness of endoscopic early diagnosis and treatment of…

Intestinal Cell Death in Necrotising Enterocolitis

Necrotising enterocolitis (NEC) is a serious gastrointestinal clinical disorder primarily affecting preterm newborns. It is characterised…

Microbiota in Clinical Practice: What is New and What is True?

INCREASING interest in the microbiome can be linked to its great diagnostic and treatment potential, the extent of which…

UEG 2023 Abstract Highlights

The following stories summarise a selection of the top abstracts presented at United European Gastroenterology (UEG) Week 2023. These…

Rise of the Machines in Digestive Diseases

The human microbiome was integral to the presentation delivered by Edoardo Pasolli, University of Naples Federico II, Italy…

Roundtable: Was it worth the risk?

With compliance and regulatory hoops to jump through, medical affairs teams can be reluctant to try new tactics. This roundtable uncovers their relationship with risk and asks what the future holds.

Screening Intervals for Diabetic Retinopathy Can be Extended in Low-Risk Patients

A systematic recent review suggested that extending diabetic retinopathy screening intervals to 3–5 years may be safe under certain circumstances, potentially leading to reduced healthcare costs, and a lighter workload for medical professionals.

From Gut to Glory: The Potential of Gut Hormones in Type 2 Diabetes Management

This podcast series explores the latest developments in the management of type 2 diabetes, with a specific focus on gut hormones and the comprehensive approach to understanding patient profiles.

Is the Risk of Colorectal Cancer Higher in Those With Type 2 Diabetes?

Findings from a cohort study have indicated that the risk for developing colorectal cancer is increased by up to 47% amongst patients with Type 2 diabetes. Read more.